FIGS (FIGS) Tops Q2 EPS by 19c, Revs Beat

FIGS (NYSE: FIGS) reported Q2 EPS of $0.08, $0.19 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $101.1 million versus the consensus estimate of $86.63 million.

“We are extremely pleased to have delivered strong financial performance in our first quarter as a public company following a successful IPO. We are so proud to have completed our public offering in the only way we could have imagined – by ringing the bell with as many Awesome Humans as we could fit on the podium right alongside us,” said Co-Chief Executive Officers Heather Hasson and Trina Spear. “Healthcare professionals deserve to be celebrated, empowered, and served, and that's what we aim to do every day. The way we executed and grew our business in Q2 was another step in that direction. We generated over $100 million in net revenues, we grew to 1.6 million active customers, and we continued to drive growth in a sustainable way. Thank you to the entire FIGS team, and most importantly, to all the healthcare professionals who serve and inspire all of us on a daily basis. We will continue to make investments that expand your access to the best products, the most seamless direct-to-consumer experience, and to share your stories with the world.”

GUIDANCE:

FIGS sees Q3 2021 revenue of $395 million, versus the consensus of $379.8 million.

For earnings history and earnings-related data on FIGS (FIGS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters